RF MICRO DEVICES® and RFMD® are trademarks of RFMD, LLC. All other trade names, trademarks and registered trademarks are the property of their respective owners.
[Tables To Follow]
RF MICRO DEVICES, INC. AND SUBSIDIARIES
| |||||||
|
Three Months Ended | ||||||
|
June 29, 2013 |
|
June 30, 2012 | ||||
Revenue |
$ |
292,996 |
|
|
$ |
202,660 |
|
|
|
|
| ||||
Costs and expenses: |
|
|
| ||||
Cost of goods sold |
199,527 |
|
|
138,406 |
| ||
Research and development |
48,325 |
|
|
41,576 |
| ||
Marketing and selling |
19,409 |
|
|
16,878 |
| ||
General and administrative |
19,492 |
|
|
13,395 |
| ||
Other operating expense |
3,008 |
|
|
5,272 |
| ||
Total costs and expenses |
289,761 |
|
|
215,527 |
| ||
|
|
|
| ||||
Income (loss) from operations |
3,235 |
|
|
(12,867) |
| ||
Other expense |
(1,060) |
|
|
(3,455) |
| ||
|
|
|
| ||||
Income (loss) before income taxes |
$ |
2,175 |
|
|
$ |
(16,322) |
|
Income tax expense |
(614) |
|
|
(2,817) |
| ||
|
|
|
| ||||
Net income (loss) |
$ |
1,561 |
|
|
$ |
(19,139) |
|
|
|
|
| ||||
|
|
|
| ||||
Net income (loss) per share, diluted |
$ |
0.01 |
|
|
$ |
(0.07) |
|
|
|
|
| ||||
Weighted average outstanding diluted shares |
287,105 |
|
|
277,144 |
|
RF MICRO DEVICES, INC. AND SUBSIDIARIES
| |||||||||||
|
Three Months Ended | ||||||||||
|
June 29, 2013 |
|
March 30, 2013 |
|
June 30, 2012 | ||||||
|
|
|
|
|
| ||||||
GAAP operating income (loss) |
$ |
3,235 |
|
|
$ |
1,657 |
|
|
$ |
(12,867) |
|
Share-based compensation expense |
9,433 |
|
|
6,695 |
|
|
5,746 |
| |||
Amortization of intangible assets |
7,217 |
|
|
7,327 |
|
|
4,572 |
| |||
Acquired inventory step-up and revaluation |
— |
|
|
582 |
|
|
— |
| |||
Restructuring and disposal costs associated with the phase
|
4,555 |
|
|
1,365 |
|
|
— |
| |||
Certain consulting costs |
2,200 |
|
|
— |
|
|
— |
| |||
IPR litigation costs |
824 |
|
|
1,264 |
|
|
743 |
| |||
Loss on an asset transfer transaction |
— |
|
|
— |
|
|
5,042 |
| |||
Other expenses (restructuring, acquisition-related costs,
|
519 |
|
|
1,718 |
|
|
652 |
| |||
Non-GAAP operating income |
27,983 |
|
|
20,608 |
|
|
3,888 |
| |||
|
|
|
|
|
| ||||||
GAAP net income (loss) |
1,561 |
|
|
(15,961) |
|
|
(19,139) |
| |||
Share-based compensation expense |
9,433 |
|
|
6,695 |
|
|
5,746 |
| |||
Amortization of intangible assets |
7,217 |
|
|
7,327 |
|
|
4,572 |
| |||
Acquired inventory step-up and revaluation |
— |
|
|
582 |
|
|
— |
| |||
Restructuring and disposal costs associated with the phase
|
4,555 |
|
|
1,365 |
|
|
— |
| |||
Certain consulting costs |
2,200 |
|
|
— |
|
|
— |
| |||
IPR litigation costs |
824 |
|
|
1,264 |
|
|
743 |
| |||
Loss on an asset transfer transaction |
— |
|
|
— |
|
|
5,042 |
| |||
Other expenses (restructuring, acquisition-related costs,
|
519 |
|
|
1,718 |
|
|
652 |
| |||
Loss on retirement of convertible subordinated notes |
— |
|
|
— |
|
|
722 |
| |||
Non-cash interest expense on convertible subordinated notes |
1,261 |
|
|
1,266 |
|
|
1,805 |
| |||
(Income) loss from equity investment |
(98) |
|
|
(95) |
|
|
102 |
| |||
Tax adjustments |
(1,919) |
|
|
12,932 |
|
|
2,442 |
| |||
|
|
|
|
|
| ||||||
Non-GAAP net income |
$ |
25,553 |
|
|
$ |
17,093 |
|
|
$ |
2,687 |
|
|
|
|
|
|
| ||||||
GAAP weighted average outstanding diluted shares |
287,105 |
|
|
279,612 |
|
|
277,144 |
| |||
Diluted share-based awards |
— |
|
|
5,930 |
|
|
5,043 |
| |||
Non-GAAP weighted average outstanding diluted shares |
287,105 |
|
|
285,542 |
|
|
282,187 |
| |||
|
|
|
|
|
| ||||||
Non-GAAP net income per share, diluted |
$ |
0.09 |
|
|
$ |
0.06 |
|
|
$ |
0.01 |
|
|
|
|
|
|
|